511509 Stock Overview
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Vivo Bio Tech Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹45.57 |
| 52 Week High | ₹56.00 |
| 52 Week Low | ₹21.05 |
| Beta | 0.84 |
| 1 Month Change | 0.35% |
| 3 Month Change | 17.69% |
| 1 Year Change | 75.54% |
| 3 Year Change | -26.20% |
| 5 Year Change | -13.20% |
| Change since IPO | -36.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 511509 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 2.0% | -0.1% | 1.4% |
| 1Y | 75.5% | 17.4% | 46.1% |
Return vs Industry: 511509 exceeded the Indian Life Sciences industry which returned 17.4% over the past year.
Return vs Market: 511509 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| 511509 volatility | |
|---|---|
| 511509 Average Weekly Movement | 8.3% |
| Life Sciences Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 511509 has not had significant price volatility in the past 3 months.
Volatility Over Time: 511509's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 150 | Alangudi Sankaranarayanan | www.vivobio.com |
Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vitro, in vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, analytical services, etc. It also supplies SPF lab animals; and rodent models, cyagen biosciences, custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory IND enabling preclinical development services; screening and evaluating molecules for various pharmacological and therapeutic properties; and design and development of syngeneic / xenograft models for evaluation of anti-cancer agents.
Vivo Bio Tech Limited Fundamentals Summary
| 511509 fundamental statistics | |
|---|---|
| Market cap | ₹666.78m |
| Earnings (TTM) | ₹38.54m |
| Revenue (TTM) | ₹484.51m |
17.6x
P/E Ratio1.4x
P/S RatioIs 511509 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 511509 income statement (TTM) | |
|---|---|
| Revenue | ₹484.51m |
| Cost of Revenue | ₹44.03m |
| Gross Profit | ₹440.48m |
| Other Expenses | ₹401.95m |
| Earnings | ₹38.54m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.59 |
| Gross Margin | 90.91% |
| Net Profit Margin | 7.95% |
| Debt/Equity Ratio | 115.0% |
How did 511509 perform over the long term?
See historical performance and comparison